
Randall H. Gholson
Examiner (ID: 10359, Phone: (571)272-1011 , Office: P/2918 )
| Most Active Art Unit | 2918 |
| Art Unit(s) | 2915, 2918 |
| Total Applications | 3041 |
| Issued Applications | 3007 |
| Pending Applications | 0 |
| Abandoned Applications | 34 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17005437
[patent_doc_number] => 20210236598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => METHODS FOR ORGAN REGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/165286
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165286 | METHODS FOR ORGAN REGENERATION | Feb 1, 2021 | Abandoned |
Array
(
[id] => 16856112
[patent_doc_number] => 20210156857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => Immunoassay Methods Utilizing Trapping Conjugate
[patent_app_type] => utility
[patent_app_number] => 17/165116
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165116 | Immunoassay Methods Utilizing Trapping Conjugate | Feb 1, 2021 | Abandoned |
Array
(
[id] => 16966027
[patent_doc_number] => 20210217526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => CANCER DIAGNOSIS USING OPTIMAL CLUSTERING WITH SUCCESSIVE DECONVOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/145385
[patent_app_country] => US
[patent_app_date] => 2021-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145385 | CANCER DIAGNOSIS USING OPTIMAL CLUSTERING WITH SUCCESSIVE DECONVOLUTION | Jan 9, 2021 | Abandoned |
Array
(
[id] => 16899054
[patent_doc_number] => 20210177970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Multifunctional Treatment And Diagnostic Compositions And Methods
[patent_app_type] => utility
[patent_app_number] => 17/130819
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17130819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/130819 | Multifunctional Treatment And Diagnostic Compositions And Methods | Dec 21, 2020 | Abandoned |
Array
(
[id] => 18183253
[patent_doc_number] => 20230043983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => AQUEOUS COMPOSITION COMPRISING A CATIONIC POLYMER, AN ANIONIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT
[patent_app_type] => utility
[patent_app_number] => 17/785003
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785003
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785003 | AQUEOUS COMPOSITION COMPRISING A CATIONIC POLYMER, AN ANIONIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT | Dec 10, 2020 | Abandoned |
Array
(
[id] => 18286275
[patent_doc_number] => 20230101747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => CYCLIC COMPOUNDS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/781559
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -232
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781559 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | Dec 2, 2020 | Pending |
Array
(
[id] => 18091202
[patent_doc_number] => 20220409543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => DEPOSITION OF NANOSUSPENSIONS OF ACTIVE PHARMACEUTICAL INGREDIENTS ON CARRIERS
[patent_app_type] => utility
[patent_app_number] => 17/776368
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776368
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776368 | DEPOSITION OF NANOSUSPENSIONS OF ACTIVE PHARMACEUTICAL INGREDIENTS ON CARRIERS | Nov 26, 2020 | Abandoned |
Array
(
[id] => 18108053
[patent_doc_number] => 20230000933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => AGENT FOR PREVENTION OR REMEDIATION OF STRESS DISORDERS AND COMPOSITION CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/782136
[patent_app_country] => US
[patent_app_date] => 2020-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782136 | AGENT FOR PREVENTION OR REMEDIATION OF STRESS DISORDERS AND COMPOSITION CONTAINING SAME | Nov 25, 2020 | Abandoned |
Array
(
[id] => 18110859
[patent_doc_number] => 20230003739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => OPTICAL METHOD FOR DETECTING A TARGET MOLECULE BY MEANS OF THE AMPLIFICATION IN THE INTERFERENCE RESPONSE, RESULTING FROM THE REFRACTIVE INDEX AND DISPERSION
[patent_app_type] => utility
[patent_app_number] => 17/781697
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781697
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781697 | OPTICAL METHOD FOR DETECTING A TARGET MOLECULE BY MEANS OF THE AMPLIFICATION IN THE INTERFERENCE RESPONSE, RESULTING FROM THE REFRACTIVE INDEX AND DISPERSION | Nov 24, 2020 | Pending |
Array
(
[id] => 18649355
[patent_doc_number] => 20230295152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/756243
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17756243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/756243 | PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS | Nov 19, 2020 | Pending |
Array
(
[id] => 17157269
[patent_doc_number] => 20210318320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => CALIBRATOR FOR IMMUNOASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/952473
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952473
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952473 | CALIBRATOR FOR IMMUNOASSAYS | Nov 18, 2020 | Abandoned |
Array
(
[id] => 18056322
[patent_doc_number] => 20220387408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
[patent_app_type] => utility
[patent_app_number] => 17/776075
[patent_app_country] => US
[patent_app_date] => 2020-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776075 | USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION | Nov 9, 2020 | Abandoned |
Array
(
[id] => 18034708
[patent_doc_number] => 20220378923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => BET DEGRADER
[patent_app_type] => utility
[patent_app_number] => 17/764883
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 114908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 364
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764883 | BET DEGRADER | Sep 29, 2020 | Pending |
Array
(
[id] => 17806307
[patent_doc_number] => 20220258142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METALLOSILICATE CATALYST SOLVENT WASH
[patent_app_type] => utility
[patent_app_number] => 17/626156
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626156 | METALLOSILICATE CATALYST SOLVENT WASH | Sep 28, 2020 | Abandoned |
Array
(
[id] => 17961352
[patent_doc_number] => 20220341933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/761767
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761767 | A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS | Sep 24, 2020 | Pending |
Array
(
[id] => 18091375
[patent_doc_number] => 20220409716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => T-CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/763548
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763548 | T-CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Sep 23, 2020 | Pending |
Array
(
[id] => 18987689
[patent_doc_number] => 20240059658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/642032
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642032 | QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER | Sep 9, 2020 | Abandoned |
Array
(
[id] => 17896978
[patent_doc_number] => 20220306640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => HYDANTOIN DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/638375
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638375
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638375 | HYDANTOIN DERIVATIVE | Sep 3, 2020 | Abandoned |
Array
(
[id] => 17837938
[patent_doc_number] => 20220275243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => SURFACE FUNCTIONALIZED SUBSTRATES AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/635572
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635572 | SURFACE FUNCTIONALIZED SUBSTRATES AND METHODS OF MAKING THE SAME | Aug 19, 2020 | Pending |
Array
(
[id] => 17836414
[patent_doc_number] => 20220273719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => GENETICALLY MODIFIED NK CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/632877
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632877 | GENETICALLY MODIFIED NK CELLS AND USES THEREOF | Aug 10, 2020 | Abandoned |